March 17, 2008 – Dr. Smith presented "Advances in Understanding and Treating ALS" at the Muscular Dystrophy Association office in San Diego, CA.
Dr. Licht headed a Gene Therapy Trial with the goal of slowing or reversing nerve damage associated with diabetes. The nationwide study is sponsored by Sangamo BioSciences.
UCSD and CNS receive million dollar plus grant to develop a therapy for familial ALS. The award was made by the Muscular Dystrophy Association.